Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Characterizing a possible cellular and animal model of clear cell renal cell carcinoma
FY 2020-21
Summary
In 2019, kidney cancer represented approximately 3% of all cancer cases and 2% of cancer deaths in Canada. Most patients are diagnosed with a type called clear cell renal cell carcinoma (ccRCC), which is often aggressive and resistant to conventional cancer therapies such as chemotherapy and radiation therapy. Once it becomes metastatic, which is when the cancer has spread beyond its original site, ccRCC is associated with low survival rates. However, in current research on ccRCC, cells that are used to model this disease often do not look similar to what is seen in ccRCC tumours. Furthermore, there is a lack of models for metastatic ccRCC, which limits our ability to understand the mechanisms involved in cancer growth and metastasis. Recently, our collaborators have established ccRCC cells that look more similar to those seen in tumours, which may represent a more relevant model to conduct kidney cancer research. As a result, we want to investigate this possible cellular and animal model of ccRCC that can allow us to have a better understanding of the disease process. To do this, we aim to identify possible differences between cancer cells grown on a plate and cells that are grown in the kidneys of mice, in order to see if this will affect the testing of cancer drugs, which is often performed on cells that are grown on plates. Furthermore, we want to create a model with metastatic cells, which remains elusive, in order to perform experiments to investigate mechanisms within the cell and test therapeutics. By investigating these aims, we want to understand if these cells are more relevant for ccRCC, which can potentially allow for its use as a more widespread model that can assist in identifying mechanisms in ccRCC and in the development of cancer therapeutics.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
449753
Name
Huang Richard
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterizing a possible cellular and animal model of clear cell renal cell carcinoma
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer Therapeutics; Cellular And Animal Models; Clear Cell Renal Cell Carcinoma; Kidney Cancer; Malignant Transformation; Metastasis; Single-Cell Rna Sequencing; Von Hippel-Lindau Disease
Abstract
In 2019, kidney cancer represented approximately 3% of all cancer cases and 2% of cancer deaths in Canada. Most patients are diagnosed with a type called clear cell renal cell carcinoma (ccRCC), which is often aggressive and resistant to conventional cancer therapies such as chemotherapy and radiation therapy. Once it becomes metastatic, which is when the cancer has spread beyond its original site, ccRCC is associated with low survival rates. However, in current research on ccRCC, cells that are used to model this disease often do not look similar to what is seen in ccRCC tumours. Furthermore, there is a lack of models for metastatic ccRCC, which limits our ability to understand the mechanisms involved in cancer growth and metastasis. Recently, our collaborators have established ccRCC cells that look more similar to those seen in tumours, which may represent a more relevant model to conduct kidney cancer research. As a result, we want to investigate this possible cellular and animal model of ccRCC that can allow us to have a better understanding of the disease process. To do this, we aim to identify possible differences between cancer cells grown on a plate and cells that are grown in the kidneys of mice, in order to see if this will affect the testing of cancer drugs, which is often performed on cells that are grown on plates. Furthermore, we want to create a model with metastatic cells, which remains elusive, in order to perform experiments to investigate mechanisms within the cell and test therapeutics. By investigating these aims, we want to understand if these cells are more relevant for ccRCC, which can potentially allow for its use as a more widespread model that can assist in identifying mechanisms in ccRCC and in the development of cancer therapeutics.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Huang, Richard
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~